We are pleased to inform the NU community that pilot access to the CAS BioFinder Discovery Platform is available from September 14 through November 14, 2026. The resource has been added to the A-Z List.
CAS BioFinder brings together comprehensive pharmaceutical data and advanced solutions to support drug discovery research, including discovery biology and medicinal chemistry. The platform provides access to data that can be searched by ligand, target, and disease, supported by predictive technologies and knowledge graphs.
The CAS BioFinder Discovery Platform® provides access to:
Published and predicted bioactivity data
Ligand-protein interactions
Biomarkers
Comprehensive pharmaceutical and drug discovery data
Access has been provided to all existing and active users. New users must first create a SciFinder account.
We encourage interested members of the NU community to take advantage of this pilot access and explore the platform's capabilities for drug discovery research.